
CAS Name: 4-O-b-D-Galactopyranosyl-D-gluconic acid compd with erythromycin (1:1)
Trademarks: Erythrocin Lactobionate (Abbott)
Literature References: Semi-synthetic macrolide antibiotic prepd from erythromycin base and lactobiono-d-lactone in water-acetone: Hoffhine, US 2761859 (1956 to Abbott); alternate prepn and antibacterial activity: S. K. Dutta, K. S. Basu, US 4137397 (1979 to Jadavpur Univ.). Pharmacokinetics: R. L. Parsons et al., J. Int. Med. Res. 8, suppl. 2, 15 (1980).
CAS Name: Oleandomycin triacetate ester
Additional Names: triacetyloleandomycinTrademarks: Cyclamycin (Wyeth); Wytrion (Wyeth); Evramycin (Wyeth); TAO (Roerig); Triocetin (OFF)
Percent Compo...
Literature References: Semi-synthetic macrolide antibiotic. Prepd from oleandomycin: Celmer et al., Antibiot. Annu. 1957-1958, p 476; GB 877730 (1958 to Pfizer); M. Khristov, N. Petkov, Farmatsiya (Sofia) 27, 1 (1977), C.A. 90, 23458c (1979). Review: S. Ross, Antimicrobial Therapy, B. M. Kagan, Ed. (Saunders, Philadelphia, 1970) pp 134-144.
CAS Name: Erythromycin octadecanoate (salt)
Trademarks: Abboticine (Abbott); Bristamycin (BMS); Dowmycin E (Dow); Erypar (Parke-Davis); Eryprim (Scarium); Erythro S (Sanko); Erythrocin (Abbott)...
Literature References: Semi-synthetic macrolide antibiotic. Prepn: O. F. Walasek, US 2881163 (1959 to Abbott). Bioavailability: A.-S. Malmborg, J. Antimicrob. Chemother. 5, 591 (1979). Pharmacokinetics and tolerance: D. C. Shanson et al., ibid. 14, 157 (1984). Clinical efficacy in respiratory tract infections: J. P. Butler et al., Chemotherapy (Basel) 25, 367 (1979); in acute otitis media: C. Rosen et al., Acta Otolaryngol. (Stockholm) Suppl. 407, 23 (1984). Prepn of erythromycin stearate (ester): Booth, Murray, US 2862921 (1958 to Upjohn).
CAS Name: D-glycero-D-gulo-Heptonic acid compd with erythromycin (1:1)
Additional Names: erythromycin glucoheptonic acid salt; erythromycin gluceptate
Trademarks: Ilotycin Gluceptate (Lilly)...
Literature References: Semi-synthetic macrolide antibiotic. Prepn: Shepler, US 2852429 (1958 to Lilly).
CAS Name: Erythromycin 2'-propanoate
Additional Names: propionylerythromycin; monopropionylerythromycin
Trademarks: Propiocine (Hoechst)
Percent Composition: C 60.81%, H 9.06%, N 1.77%, O...
Literature References: Semi-synthetic macrolide antibiotic. Prepn: V. C. Stephens, US 2993833 (1961 to Lilly); V. C. Stephens, J. W. Conine, Antibiot. Annu. 1958-59, 346. Pharmacology and toxicology: C. Lee et al., ibid. 354. Clinical studies: R. S. Griffith, ibid. 364; D. M. Perry et al., ibid. 375. Clinical pharmacokinetics: M. Ducci et al., Int. J. Clin. Pharmacol. Ther. Toxicol. 19, 494 (1981). HPLC determn in plasma: W. Xiao et al., J. Chromatogr. B 817, 153 (2005).
CAS Name: 6-O-MethylerythromycinTrademarks: Biaxin (Abbott); Clarosip (Grñenthal); Clathromycin (Taisho); Cyllind (Abbott); Klacid (Abbott); Klaricid (Abbott); Macladin (Guidotti); Naxy (Sanofi Wi...
Literature References: Semisynthetic macrolide antibiotic; derivative of erythromycin, q.v. Prepn: Y. Watanabe et al., EP 41355; eidem, US 4331803 (1981, 1982 both to Taisho); and in vitro antibacterial activity: S. Morimoto et al., J. Antibiot. 37, 187 (1984). In vitro and in vivo antibacterial activity: P. B. Fernandes et al., Antimicrob. Agents Chemother. 30, 865 (1986). Comparative antibacterial spectrum in vitro: C. Benson et al., Eur. J. Clin. Microbiol. 6, 173 (1987); H. M. Wexler, S. M. Finegold, ibid. 492. HPLC determn in biological fluids: D. Croteau et al., J. Chromatogr. 419, 205 (1987); in plasma: H. Amini, A. Ahmadiani, J. Chromatogr. B 817, 193 (2005). Acute toxicity study: S. Abe et al., Chemotherapy (Tokyo) 36, Suppl. 3, 274 (1988). Symposium on pharmacology and comparative clinical studies: J. Antimicrob. Chemother. 27, Suppl. A, 1-124 (1991). Comprehensive description: I. I. Salem, Anal. Profiles Drug Subs. Excip. 24, 45-85, (1996).
CAS Name: (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dime...
Literature References: Semi-synthetic macrolide antibiotic; related to erythromycin A, q.v. Prepn: BE 892357; G. Kobrehel, S. Djokic, US 4517359 (1982, 1985 both to Sour Pliva); of the crystalline dihydrate: D. J. M. Allen, K. M. Nepveux, EP 298650; eidem, US 6268489 (1989, 2001 both to Pfizer). Antibacterial spectrum: S. C. Aronoff et al., J. Antimicrob. Chemother. 19, 275 (1987); and mode of action: J. Retsema et al., Antimicrob. Agents Chemother. 31, 1939 (1987). Series of articles on pharmacology, pharmacokinetics, and clinical experience: J. Antimicrob. Chemother. 31, Suppl. E, 1-198 (1993). Clinical trial in prevention of Pneumocystis carinii pneumonia in AIDS patients: M. W. Dunne et al., Lancet 354, 891 (1999). Review of pharmacology and clinical efficacy in pediatric infections: H. D. Langtry, J. A. Balfour, Drugs 56, 273-297 (1998).
CAS Name: (6R-cis)-7-[[[(Difluoromethyl)thio]acetyl]amino]-3-[[[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]thio]methyl]-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Additional ...
Literature References: Semi-synthetic oxacephalosporin antibiotic. Prepn: T. Tsuji et al., BE 898541; eidem, US 4532233 (1984, 1985 both to Shionogi); eidem, J. Antibiot. 38, 466 (1985). In vitro activity and b-lactamase stability: H. C. Neu, N.-X. Chin, Antimicrob. Agents Chemother. 30, 638 (1986).
CAS Name: (2R)-N-Methyl-D-asparaginyl-N-[(2S,5R,6R)-2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-6-yl]-D-2-(4-hydroxyphenyl)glycinamide
Additional Names: 6-[D-2-(D-2-amino-3-N-me...
Literature References: Semisynthetic penicillin. Prepn: M. Kawazu et al., DE 2638067; eidem, US 4053609 (both 1977 to Tanabe); prepn and antibacterial activity: M. Wagatsuma et al., J. Antibiot. 36, 147 (1985). Mechanism of action study: T. Nishino et al., Chemotherapy (Tokyo) 33, 132 (1985), C.A. 103, 34792v (1985). Toxicological study: M. Takeshita et al., Oyo Yakuri 30, 687 (1985), C.A. 104, 101990u (1986). HPLC determn in serum: J. Knöller et al., Zentralbl. Bakteriol. Mikrobiol. Hyg. 265, 176 (1987). Clinical evaluation in ocular infections: M. Ooishi et al., Acta Med. Biol. 34, 1 (1986). Series of articles on antibacterial activity, pharmacology and clinical efficacy: Chemotherapy (Tokyo) 32, Suppl. 2, 1-791 (1984).
CAS Name: (2R,3S,4S,5R,6S)-Tetrahydro-2,4-dihydroxy-6-[(1R)-1-[(2S,5R,7S,8R,9S)-9-hydroxy-2,8-dimethyl-2-[(2S,2'R,3'S,5R,5'R)-octahydro-2-methyl-5'-[(2S,3S,5R,6S)-tetrahydro-6-hydroxy-3,5,6-trimet...
Literature References: Semi-synthetic polyether ionophore antibiotic. Prepn: A. C. Goudie, N. D. A. Walshe, EP 255335; eidem, US 4804680 (1988, 1989 both to Pfizer). LC determn in poultry liver: J. F. Ericson et al., J. AOAC Int. 77, 577 (1994). Metabolism and tissue residue studies in broiler chickens: M. J. Lynch et al., ACS Symp. Ser. 503, 49-69 (1992). Anticoccidial effects in chickens: M. E. McKenzie et al., Poult. Sci. 72, 2052 (1993); N. B. Logan et al., ibid., 2058.
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
